
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
HyperMabs is a biopharmaceutical company that designs and develops innovative monoclonal antibody-based therapeutics for life threatening diseases including COVID-19. We believe in connecting rigorous science with our innate sense of urgency to rapidly generate breakthrough therapies for patients in need of a better quality of life. Our highly qualified team of drug developers and company builders has a track record of advancing complex biologics from discovery through clinical trials
Hypermabs inc operates in the Biotechnology research industry.
Hypermabs inc's revenue is 11m - 100m
Hypermabs inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.